The majority of patients with cancer use some form of complementary or alternative medicine. External qigong treatment (EQT), classified as a bioenergy therapy, is one such approach that patients combine with conventional medicine or, in some cases, use in place of conventional medicine. This study aimed to determine whether EQT could shrink breast cancer tumors and improve quality of life (QOL) in women with pathologically confirmed breast cancer awaiting surgery. A total of 9 women with pathologically confirmed breast cancer were recruited from large cancer centers in the United States (n = 5) and China (n = 4). A single-arm pre/post design was used. Each patient underwent 5 consecutive days of EQT, with each treatment lasting from 2 to 5 minutes. All treatments were performed by the same qigong master. Tumor measurements were made before and after the EQT sessions. Tumor assessments were conducted prior to study initiation and following the last EQT. Patients underwent both an ultrasound and mammogram (United States) or an ultrasound and magnetic resonance imaging (China). All patients also underwent physical breast examinations (PBEs) and completed QOL questionnaires before and after the last EQT. No clinical changes in tumor measurements from pre-to post-EQT were noted. There was also no suggestion of change in tumor size by PBE or change in QOL. Using the current study design, EQT did not have any effect on tumor size. EQT also does not appear to have any effect on patient QOL. Because of the small sample size and working with only one qigong practitioner, to definitively determine the efficacy or lack of efficacy of EQT, a larger study with multiple qigong practitioners would need to be conducted.
Introduction
The majority of people diagnosed with cancer use some form of complementary and alternative medicine (CAM). 1, 2 Although most patients will combine alternative approaches with conventional medicine (complementary medicine), some patients do in fact decline curative conventional treatments in favor of more nontoxic alternative approaches. Qigong is one such approach that patients combine with conventional medicine or use in place of conventional medicine.
Qigong is classified as a bioenergy therapy with a long history of therapeutic use for many diseases, including cancer. Qigong is composed of two terms: qi, which means energy flow and gong, which means skill or achievement. 3 The 4 main components of qigong include training in consciousness, breathing, body movement, and adjustment or stimulation of one's own qi. Qigong is practiced in two general ways: internally and externally. External qigong is conducted by having a qigong master emit his own qi to assist in clearing blockages of qi or in balancing the qi in another individual. 4 Although there is evidence for the benefits of the self-practice internal qigong in terms of quality of life (QOL) and biological outcomes, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] there has been less research on external qigong treatment (EQT).
Reports in the Chinese-language literature in preclinical models suggest that EQT can suppress cancer growth in vitro. 25 A recent publication in English examined the effects of a related energy therapy, therapeutic touch (TT), and showed that TT significantly increased human osteoblast proliferation, matrix synthesis, and bone formation, and it inhibited differentiation and bone formation in SaOs-2 cultures. 26 Although there has been some research examining the use of EQT on cancer growth in vivo with encouraging results, no peerreviewed research or clinical trials of EQT have been published in the English-language literature. 25 Given the limitations of the preclinical and clinical studies, there is no clear evidence suggesting that this treatment will provide any benefit to women with breast cancer. Most studies of EQT have been anecdotal or poorly controlled and many reports were not published in peer-reviewed journals. As patients continue to seek out EQT as a way to improve clinical outcomes, it is important to document whether or not there is any benefit to this intervention. We sought to explore whether EQT had any effect on tumor size and QOL in women with breast cancer who were awaiting surgery.
Methods Participants
The trial was initially conducted at The University of Texas M. D. Anderson Cancer Center in Houston, Texas and subsequently at the Fudan University Cancer Hospital (Cancer Hospital) in Shanghai, China. Five patients were treated at M. D. Anderson and 4 at Cancer Hospital. Inclusion criteria were: women with untreated, ≤3 cm, and pathologically confirmed breast cancer awaiting surgery.
Procedures
Consecutive patients were approached prior to surgery who met the basic inclusion criteria. Patients who were interested in the study, had enough time between recruitment and surgery to complete the study, and were willing to undergo the 5 EQT sessions prior to surgery provided written informed consent before having a pretreatment evaluation that included completion of QOL questionnaires, imaging studies, and physical breast examination (PBE) no more than 2 weeks before the start of EQT. Patients then received 5 consecutive days of daily EQT. After the last session, patients underwent radiographic measurements, a PBE, and completed QOL questionnaires. Patients then had their scheduled surgery for their breast cancer. Patients' parking and transportation costs were paid by the study, and they received a $100 gift certificate for each imaging study they completed as compensation for their time. The protocol was approved by the Institutional Review Boards of both institutions.
External Qigong Intervention
Mr Binhui He, the qigong master who delivered the EQT, is a prominent qigong master from China and has practiced qigong for 40 years. He is the 48th lineage holder of the secret Taiji Men and the creator of Chinese Taiji Five-Element qigong. With years of clinical experience, he has reportedly helped more than 10,000 patients with various chronic diseases, including cancer.
Each session was conducted individually. Patients stood relaxed facing the qigong master and were instructed to close their eyes, relax, and focus on their pelvis. The master then used words and visualizations and held his hands about 10 to 15 cm away from the affected breast. With a deep breath he would then emit a loud shout to discharge strong qi toward the breast tumor while instructing the tumor to "shrink," become "softer," and "disappear." The individual qi adjustments took 2 to 5 minutes, based on Mr He's discretion. The qigong master spoke Mandarin during the sessions. There was a research nurse present during the treatments as well as a translator translating for what Mr He said for all the M. D. Anderson patients.
Measures
Imaging studies. At M. D. Anderson, each patient underwent mammogram and ultrasound. At Cancer Hospital, each patient underwent ultrasound and magnetic resonance imaging (MRI). All imaging was interpreted at time of assessment by a radiologist. On completion of the study, all imaging exams were interpreted by two M. D. Anderson radiologists who were blinded to clinical information, pathology, and time of imaging exams. The three longest dimensions were recorded and longest of the three was reported (see Table 1 ).
Physical exam. All patients underwent a standard PBE.
Questionnaires. The Functional Assessment of Cancer Therapy-General (FACT-G) was used to measure cancerspecific QOL. 27 Distress symptoms were measured by the Brief Symptom Inventory-18 (BSI). 28 This widely used symptom inventory, an 18-item version of the Brief Symptom Inventory-53, 29 yields an overall distress score as well as subscale scores gauging somatization, anxiety, and depression. Cancer-related symptoms were assessed using the M. D. Anderson Symptom Inventory (MDASI) assessing symptoms that are common across all cancer diagnoses and treatments. 30 
Results
In all, 15 patients were approached at M. D. Anderson and 5 agreed to participate. Reasons for declining included the following: scheduling difficulties, inadequate time to participate, or disinterest in EQT. At Cancer Hospital, 8 patients were approached and 4 agreed to participate. Patients declined because they were disinterested in or feared EQT, fear of undergoing MRI, or desire to forgo surgery if the tumor disappeared. All patients underwent all 5 EQT sessions.
No clinically meaningful changes from pre-to post-EQT in ultrasound exams (patients from both hospitals), mammograms (M. D. Anderson only; 2 patients could not be accurately measured due to tumor location), or MRI (Cancer Hospital only) were found (see Table 1 ). There was also no suggestion of change in tumor size from the PBE (data not shown). QOL data was examined using nonparametric signed rank test; no significant changes over time for any of the measures were noted (see Table 2 ).
Discussion
We embarked on this study based on reports in the literature and anecdotal stories that small breast tumors could shrink and/or disappear through the use of EQT. In fact, there have been reports that some women with early-stage breast cancer forego surgery in favor of this form of "energy" therapy. In the absence of published research that EQT does not work, patients could only be counseled that it was unlikely that EQT would work based on our understanding of the laws of physics, notwithstanding that there had been no clinical trials demonstrating the benefit or lack thereof. Previous studies and anecdotal reports have been poorly conducted, and none featured pathologically documented cancers and blind assessments of radiologic scans. The present study is the first to our knowledge to provide evidence using a well-controlled protocol examining the effects of EQT on tumor size. Under the current research design, EQT did not have any effect on tumor size or measures of patient QOL. The first 5 patients in the study were recruited and treated at M. D. Anderson. On finding no change in tumor size per mammogram and ultrasound, we sought to understand some of the differences between the patient population of the patients recruited from M. D. Anderson and patients Mr He had worked with in the past. There were 4 main differences: (a) language differences (Mandarin vs English speaking), (b) cultural understanding of concepts of qi, (c) method of patient recruitment (patients seeking out Mr He vs researchers approaching patients who did not seek out EQT or Mr He), and (d) self-practice (although Mr He said this should not make a difference for shrinking small tumors). To overcome some of these factors, the study was also conducted at Cancer Hospital in Shanghai, China. In this way, we were able to overcome 2 of the 4 factors (language and cultural understanding). There were still no changes in tumor size per ultrasound and MRI. Although the patient population recruited did not seek out EQT independently, and the motivational aspect of the patient doing so cannot be discounted, it is likely that all patients would have wanted the EQT to work. However, this remains as a difference between the current study and the many patients who undergo EQT treatments and perceive benefits.
There are a number of other limitations with the current research that diminish the generalizability of our findings. The overall participation rate of the patients approached to participate was also less than 50%. Thus, selection bias could be a factor in the outcomes. Our sample size was also very small and change in tumor size was assessed within 1 week of the last EQT session, which is less time than it typically takes conventional chemotherapeutic treatments to show a clinical benefit. However, the current study was designed in collaboration with Mr He, and he was certain that in some cases the tumors would disappear immediately or within a few days of EQT. In Mr He's experience he indicated that this has happened in the past in as little as one EQT session, but this is based on anecdotal reports, personal experience, and/ or cases of breast cancer without pathological confirmation of disease. With an expectation that some tumors were going to disappear within a few days, a sample size of 9 patients and a follow-up of no more than 1 week was adequate to detect at least one clinical response, yet perhaps underpowered to detect changes in QOL. This study was also conducted with only one qigong practitioner. To definitively determine the efficacy or lack of efficacy of EQT, a larger study with multiple qigong practitioners would need to be conducted.
Based on the current research design and findings, although not apparently harmful, patients should be advised that EQT is not likely to have an effect on early-stage breast cancer and that undergoing conventional treatment with or without EQT is highly recommended.
Conclusions
No clinical changes in tumor measurements from pre-to post-EQT were noted. There was also no suggestion of change in tumor size by PBE or change in QOL. Using the current study design, EQT did not have any effect on tumor size. EQT also does not appear to have any effect on patient QOL.
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